Active ingredientApatinibCat. No. P-A170-001CAS 811803-05-1Family · Pharmaceutical analytical standards
Apatinib
An oral tyrosine kinase inhibitor that selectively blocks the VEGFR-2 receptor and so the growth of new blood vessels in tumours; approved in China in December 2014 for advanced gastric cancer. This family brings together the active ingredient, labelled standards and nitrosamines.
Did you know?It was first synthesised in California but approved first of all in China; its official international name (INN) is rivoceranib, while apatinib is the name it was born with.
Go to the active ingredient →Active ingredientApatinibCat. No. P-A170-001CAS 811803-05-1
Isotopically labelledApatinib-d8Cat. No. P-A170-002CAS 2468771-43-7
NitrosamineN1-Nitroso ApatinibCat. No. P-A170-003No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.